Clinical Trials Browser

Phase 4 × Brain Neoplasms × Sugammadex × Clear all

NCT05202899 2022-03-09

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Phase 4 Unknown

Brain Neoplasms

NCT02708056 2016-03-15

Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

Phase 4 Completed

Brain Neoplasms